A series of novel anthranilic diamide derivatives (5a–5ab) containing moieties of trifluoromethylpyridine
and hydrazone was
designed and synthesized. The synthesized compounds were evaluated
in vivo for their activities against tobacco mosaic virus (TMV) and
cucumber mosaic virus (CMV). Most of the synthesized compounds displayed
good to excellent antiviral activities. The compounds 5i, 5k, 5s, 5w, 5x, and 5z had the curative activity over 65% against
TMV at the concentration of 500 μg/mL, which were significantly
higher than those of ningnanmycin (55.0%) and ribavirin (37.9%). Notably,
the curative activity of compound 5i was up to 79.5%,
with the EC50 value of 75.9 μg/mL, whereas the EC50 value of ningnanmycin was 362.4 μg/mL. The pot experiments
also further demonstrated the significantly curative effect of 5i. Meanwhile, compounds 5h, 5p and 5x displayed more protective activities on TMV than that of
ningnanmycin. Moreover, compounds 5a, 5e, 5f, and 5i showed inactivation activity
similar to ningnanmycin at 500 μg/mL, and the EC50 value of 5e (41.5 μg/mL) was lower than ningnanmycin
(50.0 μg/mL). The findings of transmission electron microscopic
(TEM) indicated that the synthesized compounds exhibited strong and
significant binding affinity to TMV coat protein (CP) and could obstruct
the self-assembly and increment of TMV particles. Microscale thermophoresis
(MST) studies on TMV-CP and CMV CP revealed that some of the active
compounds, particularly 5i, exhibited a strong binding
capability to TMV-CP or CMV-CP. This study revealed that anthranilic
diamide derivatives containing moieties of trifluoromethylpyridine
and hydrazone could be used as novel antiviral agents for controlling
the plant viruses.
A series of trifluoromethyl pyridine derivatives containing 1,3,4-oxadiazole moiety was designed, synthesized and bio-assayed for their insecticidal activity. The result of bio-assays indicated the synthesized compounds exhibited good insecticidal activity against Mythimna separata and Plutella xylostella, most of the title compounds show 100% insecticidal activity at 500 mg L À1 and >80% activity at 250 mg L À1 against the two pests. Compounds E18 and E27 showed LC 50 values of 38.5 and 30.8 mg L À1 against Mythimna separata, respectively, which were close to that of avermectin (29.6 mg L À1 ); compounds E5, E6, E9, E10, E15, E25, E26, and E27 showed 100% activity at 250 mg L
À1, which were better than chlorpyrifos (87%). CoMFA and CoMSIA models with good predictability were proposed, which revealed the electron-withdrawing groups with an appropriate bulk at 2-and 4-positions of benzene ring could enhance insecticidal activity.
A series of novel α-ketoamide derivatives bearing a vanillin skeleton were designed and synthesized. Bioactivity tests on virus and bacteria were performed. The results indicated that some compounds exhibited excellent antitobacco mosaic virus (TMV) activities, such as compound 34 exhibited an inactivation activity of 90.1% and curative activity of 51.8% and compound 28 exhibited a curative activity of 54.8% at 500 μg mL −1 , which is equivalent to that of the commercial ningnanmycin (inactivation of 91.9% and curative of 51.9%). Moreover, the in vitro antibacterial activity test illustrated that compounds 2, 22, and 33 showed much higher activities than commercial thiodiazole copper, which could be used as lead compounds or potential candidates. The findings of transmission electron microscopy and molecular docking indicated that the synthesized compounds exhibited strong and significant binding affinity to the TMV coat protein and could obstruct the self-assembly and increment of TMV particles. This study revealed that α-ketoamide derivatives bearing a vanillin skeleton could be used as a novel potential pesticide for controlling the plant diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.